BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6589972)

  • 1. [Acute coronary insufficiency during induction of anesthesia following anthracycline chemotherapy].
    Pfenninger E; Ohmann C; Kilian J; Ahnefeld FW
    Anaesthesist; 1984 May; 33(5):240-3. PubMed ID: 6589972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of cardiac function in anthracycline therapy in childhood].
    Jensen E; Richter R; Mittler U; Kluba U; Aumann V
    Padiatr Grenzgeb; 1984; 23(6):455-65. PubMed ID: 6598219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of myocardiopathy during treatment of acute lymphoblastic leukemia with anthracycline antibiotics].
    Radojković B; Elezović I; Vujisić-Tesić B
    Srp Arh Celok Lek; 1988 Apr; 116(4):347-54. PubMed ID: 3187761
    [No Abstract]   [Full Text] [Related]  

  • 4. Nutritional status and anthracycline cardiotoxicity in children.
    Obama M; Cangir A; van Eys J
    South Med J; 1983 May; 76(5):577-8. PubMed ID: 6573781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature.
    Wojtacki J; Lewicka-Nowak E; Leśniewski-Kmak K
    Med Sci Monit; 2000; 6(2):411-20. PubMed ID: 11208348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.
    Zuppinger C; Timolati F; Suter TM
    Cardiovasc Toxicol; 2007; 7(2):61-6. PubMed ID: 17652805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies on cardiomyopathy induced in rabbits by various anthracyclines and anthraquinone].
    Domae N; Kagawa D; Ueda T; Goto M; Tsutani H; Uchida M; Nakamura T; Ando S; Uchino H
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2146-56. PubMed ID: 6597844
    [No Abstract]   [Full Text] [Related]  

  • 10. Anthracycline-induced cardiomyopathy in children: a report of six cases.
    Dearth J; Osborn R; Wilson E; Kelly D; Mantle J; Rogers E; Malluh A; Crist W
    Med Pediatr Oncol; 1984; 12(1):54-8. PubMed ID: 6583470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for reduction of anthracycline cardiac toxicity.
    Speyer J; Wasserheit C
    Semin Oncol; 1998 Oct; 25(5):525-37. PubMed ID: 9783592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal-averaged ECG in patients after anthracycline therapy for childhood cancer.
    Mladosievicová B; Foltinová A; Bernadic M; Hubka P; Petrásová H; Hulín I
    Neoplasma; 1998; 45(1):40-5. PubMed ID: 9605001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
    Conklin KA
    Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 16. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-induced cardiomyopathy.
    Simmons A; Vacek JL; Meyers D
    Postgrad Med; 2008 Nov; 120(4):67-72. PubMed ID: 19020367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late anthracyclines cardiotoxicity associated with infection by Mycoplasma pneumoniae. A case report.
    Valencia J; Martínez JG; Sogorb F; Niveiro M
    Int J Cardiol; 2005 Mar; 99(2):351-3. PubMed ID: 15749204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.